Acute mountain sickness: increased severity in eucapnic hypoxia.
This study examined the hypothesis that prevention of hypocapnia and alkalosis would ameliorate the symptoms of acute mountain sickness (AMS). Five subjects were exposed to simulated high altitude for 4 d with 3.8% CO2 added to the chamber to maintain normocapnia. Four other subjects were exposed for 4 d to hypobaric hypoxia without CO2 supplementation, and became hypocapnic. Barometric pressure was lower in the group with added CO2 so that alveolar oxygen tensions  (55-60 mm Hg) would not be different. The severity of symptoms was clearly greater in normocapnic than in hypocapnic subjects. Thus, prevention of hypocapnia did not alleviate AMS symptoms. The efficacy of CO2 addition in reducing symptoms, as reported by earlier workers, was probably the result of induced hyperventilation and partial relief of hypoxia. Indeed, in the present study with two comparably hypoxic groups, CO2 addition augmented the sysptoms, possibly by causing increased cerebral vasodiladation and spinal fluid pressure.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000532:Altitude Sickness / Q000150:complications*; D001273:Atmosphere Exposure Chambers; D002245:Carbon Dioxide; D002560:Cerebrovascular Circulation; D006801:Humans; D000860:Hypoxia / Q000150:complications*; D008297:Male; D008954:Models, Biological; D009051:Mountaineering; D011650:Pulmonary Alveoli; D014692:Ventilation-Perfusion Ratio
D002245:Carbon Dioxide